What is he best known for?
The fields of study he is best known for:
His primary areas of study are Genetics, Gene expression, Computational biology, Cancer and Gene.
His work on Carcinogenesis, Gene identifier and Exome as part of general Genetics study is frequently linked to Vemurafenib and Ingenuity, bridging the gap between disciplines.
His Gene expression study integrates concerns from other disciplines, such as Cancer cell, Cell culture, Gene silencing and Central nervous system.
His studies in Computational biology integrate themes in fields like Regulation of gene expression, Messenger RNA, Bioinformatics and Genomics.
The study incorporates disciplines such as Mutation, Exome sequencing, Systems pharmacology and Pharmacogenomics in addition to Cancer.
His Gene study deals with Molecular biology intersecting with Gene expression profiling.
His most cited work include:
- A gene expression database for the molecular pharmacology of cancer (1299 citations)
- GoMiner: a resource for biological interpretation of genomic and proteomic data (1128 citations)
- Expression of the vascular permeability factor/vascular endothelial growth factor gene in central nervous system neoplasms. (452 citations)
What are the main themes of his work throughout his whole career to date?
His primary scientific interests are in Genetics, Gene, Molecular biology, Cancer and Computational biology.
His research on Gene frequently links to adjacent areas such as Drug.
His research investigates the link between Molecular biology and topics such as DNA that cross with problems in Virology and Genome.
William C. Reinhold has included themes like Transcriptome, Cancer research, Mutation and DNA methylation in his Cancer study.
His Computational biology research focuses on Genomics and how it relates to Pharmacogenomics.
William C. Reinhold has researched Gene expression profiling in several fields, including Microarray and Proteomics.
He most often published in these fields:
- Genetics (31.43%)
- Gene (27.14%)
- Molecular biology (25.71%)
What were the highlights of his more recent work (between 2017-2021)?
- Computational biology (21.43%)
- Genomics (11.43%)
- Cancer (23.57%)
In recent papers he was focusing on the following fields of study:
His scientific interests lie mostly in Computational biology, Genomics, Cancer, Gene and DNA methylation.
His research in Computational biology focuses on subjects like Cancer cell lines, which are connected to Drug activity.
His Cancer research includes elements of Cancer research and Pharmacogenomics.
His research in Gene intersects with topics in Drug and Cell biology.
His work in the fields of Gene expression profiling and Gene signature overlaps with other areas such as POLD1.
His Gene expression profiling research is multidisciplinary, incorporating perspectives in Regulation of gene expression and RNA splicing.
Between 2017 and 2021, his most popular works were:
- CellMinerCDB for Integrative Cross-Database Genomics and Pharmacogenomics Analyses of Cancer Cell Lines. (62 citations)
- ONC201 kills breast cancer cells in vitro by targeting mitochondria. (34 citations)
- RNA Sequencing of the NCI-60: Integration into CellMiner and CellMiner CDB (17 citations)
In his most recent research, the most cited papers focused on:
William C. Reinhold spends much of his time researching Genomics, Gene, DNA methylation, Computational biology and Cancer systems biology.
His studies deal with areas such as Transcriptome, ASCL1, Transcription factor, YAP1 and PI3K/AKT/mTOR pathway as well as Genomics.
William C. Reinhold combines topics linked to Mitosis with his work on Gene.
His DNA methylation research includes themes of Aurora kinase, Methylation, EZH2 and Notch signaling pathway.
His biological study spans a wide range of topics, including Proteome, Gene expression, Gene expression profiling, RNA and DNA replication.
His Cancer systems biology study combines topics in areas such as Mi-2/NuRD complex, Chromatin remodeling, Proteomics and Cancer cell lines.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
